Sapienza University of Rome, Department of Oral and Maxillofacial Sciences, Section of Periodontology
Rome, 00161, Italy
Location status: Recruiting
NCT Number: NCT07683962
This study investigates whether early post-surgical healing (1-2 weeks) affects the 12-month clinical and radiographic success of periodontal regenerative therapy, and identifies patient-related, site-specific, and technique-related factors associated with optimal early wound healing, in patients with Stage III-IV periodontitis.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Rome, 00161, Italy
Location status: Recruiting
This single-center, prospective observational cohort study addresses two pre-specified aims: (1) the association between early wound healing at 1 and 2 weeks and 12-month clinical and radiographic outcomes; and (2) the identification of patient-related, site-related (e.g., intrabony defect depth, CEJ-to-bone-crest distance, defect configuration, intrabony defect classification), and technique-related (flap design, biomaterial) factors associated with optimal early wound healing.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All subjects undergo surgical debridement of the intrabony defect followed by a regenerative approach (biologics with or without bone grafts, or blood clot alone) using papilla preservation techniques (MIST, M-MIST, MPPT, SPPF, or SFA).
Time frame: Baseline and 12 months.
Time frame: 1 and 2 weeks
CHI has two independent, dichotomous domains (wound closure and wound quality), each answering a single clinically distinct question, and reports the outcome as a two-digit composite code.
Time frame: Baseline and 12 months.
Time frame: 1 and 2 weeks
Assessed using the Early Wound Healing Index (EHI). The index ranges from a minimum score of 1 (complete tissue closure without fibrin) to a maximum score of 5 (incomplete tissue closure with partial/complete necrosis). Higher scores mean a worse clinical outcome.
Time frame: Baseline and 12 months.
Measured in millimeters (mm) or degrees (°) on standardized radiographs from baseline to 12 months. It calculates the distance from a fixed reference point (e.g., cementoenamel junction) to the bottom of the bony defect. A positive change (increase in mm) indicates bone gain (better outcome).
Time frame: 1 and 2 weeks
Time frame: Baseline and 12 months
Presence or absence of bleeding assessed within 30 seconds of probing at specific sites. The data will be aggregated and reported as the percentage of sites showing bleeding out of the total sites examined. Higher percentages indicate worse outcomes.
Time frame: 12 months
Proportion of sites achieving a combination of PPD ≤ 4 mm and CAL gain ≥ 3 mm
Time frame: 12 months
Proportion of sites achieving a combination of PPD ≤ 4 mm and absence of bleeding on probing
Contact information is provided by the study sponsor or research team.
University of Roma La Sapienza
Other
Influence of Early Wound Healing on the 12-month Clinical and Radiographic Outcomes of Regenerative Periodontal Surgery: a Prospective Observational Cohort Study
Acronym: EWH_reg
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05858411
Intrabony Periodontal Defect, Mouth Diseases
Tirana, Albania
View Trial DetailsNCT06768424
Intrabony Periodontal Defect
Budapest, Hungary
View Trial DetailsNCT05442034
Intrabony Periodontal Defect
Davie, Florida, United States
View Trial DetailsNCT07146776
Alveolar Bone Loss, Bone Diseases
Istanbul, Üsküdar, Turkey (Türkiye)
View Trial Details